1302.HK
1302.HK
KYG548721177
LIFETECH SCI
Loading chart...

Company Profile

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. It is also involved in biomedical research and development; properties leasing business; and developing, manufacturing, and trading of medical devices, as well as offers technical, consulting, and technology services. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, China.

Related stocks

2190.HK
2190.HK • China
ZYLOXTB
20.5 HKD
861.68M USD 1Y -17.1%
301367.SZ
301367.SZ • China
BMC
46.71 CNY
875.66M USD 1Y -20.4%
688575.SS
688575.SS • China
SHENZHEN YHLO BIOTECH CO LTD
10.46 CNY
894.36M USD 1Y -28.1%
688626.SS
688626.SS • China
XIANGYU MEDICAL CO LTD
40.49 CNY
969.39M USD 1Y -22.7%
2697.HK
2697.HK • China
TH MEDICAL-B
183 HKD
1.2B USD
300143.SZ
300143.SZ • China
INKON LIFE
7.95 CNY
1.16B USD 1Y -9%
300206.SZ
300206.SZ • China
EDAN
11.68 CNY
1.01B USD 1Y -4.1%
600055.SS
600055.SS • China
BEIJING WANDONG MEDICAL TECHNOL
10.48 CNY
1.1B USD 1Y -41.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
48.3% p.a.
Max Drawdown (5Y)
-70.3%
Sharpe Ratio (5Y)
-0.46
Beta Factor
0.31
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 135.0 (Elevated multiple compression risk)
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (48.3% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -77.6% in the extended horizon.
ende